Addressing the impact of high glucose microenvironment on the immunosuppressive characteristics of human mesenchymal stem cells.
- Published in:
- IUBMB Life, 2024, v. 76, n. 5, p. 286, doi. 10.1002/iub.2796
- By:
- Publication type:
- Article
Works matching IS 15216543 AND DT 2024 AND VI 76 AND IP 5
Results: 6
1
2
Issue Information.
- Published in:
- IUBMB Life, 2024, v. 76, n. 5, p. 225, doi. 10.1002/iub.2743
- Publication type:
- Article
3
Fingolimod (FTY720), an FDA‐approved sphingosine 1‐phosphate (S1P) receptor agonist, restores endothelial hyperpermeability in cellular and animal models of dengue virus serotype 2 infection.
- Published in:
- IUBMB Life, 2024, v. 76, n. 5, p. 267, doi. 10.1002/iub.2795
- By:
- Publication type:
- Article
4
Viral infection and host immune response in diabetes.
- Published in:
- IUBMB Life, 2024, v. 76, n. 5, p. 242, doi. 10.1002/iub.2794
- By:
- Publication type:
- Article
5
Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS‐COV‐2 targeting main protease and papain‐like protease.
- Published in:
- IUBMB Life, 2024, v. 76, n. 5, p. 228, doi. 10.1002/iub.2793
- By:
- Publication type:
- Article
6
Cover Image.
- Published in:
- IUBMB Life, 2024, v. 76, n. 5, p. 1, doi. 10.1002/iub.2744
- Publication type:
- Article